Triton Therapeuticsa is a eveloper of novel therapeutic compounds targeting autoimmune and fibrotic diseases to improve patient outcomes.
Triton Therapeutics has raised $36.4M in total funding. The most recent round was Undisclosed. The last funding was announced in October 2025.
Triton Therapeutics is headquartered in Stamford, United States.
Triton Therapeuticsa is a eveloper of novel therapeutic compounds targeting autoimmune and fibrotic diseases to improve patient outcomes.
Triton Therapeutics is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Triton Therapeutics — Funding & Investors." VCBacked, October 23, 2025, https://www.vcbacked.co/company/triton-therapeutics. Accessed September 30, 2026.
VCBacked. (2025). Triton Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/triton-therapeutics
{{cite web |title=Triton Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/triton-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated